Report Overview

Indian Breast Cancer therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

According to the National Cancer Registry Programme (NCRP) estimates that the number of cancer cases is likely to increase from 13.9 lakh in 2020 to 15.7 lakh by 2025, an increase of nearly 20%.In India, younger women are affected (average age 40-42yrs) as compared to an average age of 55-60 years in the west. Hence, awareness of breast cancer, its symptoms, early detection, regular self-breast examination, the importance of early diagnosis and prompt treatment remains essential. Out of all the types of cancers, breast cancer has become a major health concern across Indian cities, especially in the metropolitan cities like Delhi, Bengaluru, and Chennai as it accounts for more than a fourth of all female cancers. Breast cancer is a disease of very high mortality. More than 50,000 women die of breast cancer every year in India. In Indian women, breast cancer is the second most common cancer, next only to carcinoma cervix in many urban areas. The annual percentage change in the incidence ranged from 0.46 to 2.56 for breast cancer.About 35% of HER2-positive patients reported recurrence in an average duration of 36 months, 25.88% of patients diagnosed with HER2-negative showed recurrences in an average duration of 48.8 months.



Market Driving Factors

Increase in prevalence of Breast cancer, growth in awareness about the availability of cancer treatments, growing healthcare spending for cancer and technologically advancement in therapeutics are predominantly driving the market growth. The advancement of cancer drug research owing to targeted therapies and personalized medicines hold promising opportunities for pharmaceutical, bio-pharmaceutical, and biotechnology companies engaged in developing cancer drugs. Above this, the higher cost involved in new drug development along with adverse effects associated with anti-cancer drug therapies are is rising the growth of the Breast Cancer drug market in India.